 |
|
|
| |
Clinical Outcomes in Persons Coinfected with HIV and HCV: Impact of HCV Treatment
|
| |
| |
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
L Peters1, J Lundgren1, J Rockstroh2, J Gerstoft3, LD Rasmussen4, S Bhagani5, I Aho6, C Pradier7, J Bogner8, C Mussini9, A Castagna10, F Maltez11, M Laguno12, G Wandeler13, K Falconer14, T Trofimora15, E Borodulina16, D Jevtovic17, E Bakowska18, K Kase19, G Kyselyova20, A Mocroft21 on behalf of the EuroSIDA Study
1CHIP, Rigshospitalet, Copenhagen, Denmark. 2University of Bonn, Bonn, Germany. 3Rigshospitalet, Copenhagen, Denmark. 4Odense University Hospital, Odense, Denmark. 5Royal Free Hospital, London, UK. 6Helsinki University Hospital, Helsinki, Finland. 7Centre Hospitalier Universitaire de Nice, Nice, France.8Ludwig Maximilians University of Munich, Munich, Germany. 9University of Modena and Reggio Emilia, Modena, Italy. 10San Raffaele Scientific Institute, Milano, Italy. 11Hospital de Curry Cabral, Lisbon, Portugal. 12Hospital Clinic, Barcelona, Spain. 13Bern University Hospital, Bern, Switzerland. 14Karolinska University Hospital, Stockholm, Sweden. 15Novgorod Centre for AIDS prevention and control, Novgorod the Great, Russia. 16Samara State Medical University, Samara, Russia. 17Infectious & Tropical Diseases Hospital, Belgrade, Serbia. 18Wojewodzki Szpital Zakazny, Warsaw, Poland. 19West-Tallin Central Hospital, Tallinn, Estonia. 20Crimean Republican AIDS centre, Simferopol. 21UCL, London, UK
|
| |
|
|
|
|
|
